Short-acting β-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation

Circulation

Volumn 109, Issue 20, 2004, Pages 2469-2474

  Killingsworth, Cheryl R ^a,c   Wei, Chih Chang ^a   Dell'Italia, Louis J ^a,c   Ardell, Jeffrey L ^d   Kingsley, Melody A ^a   Smith, William M ^b   Ideker, Raymond E ^a,b,c   Walcott, Gregory P ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Cardiopulmonary resuscitation; Catecholamines; Defibrillation; Norepinephrine

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; ESMOLOL; NORADRENALIN; TRITIUM;

ANIMAL EXPERIMENT; AORTA SINUS; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CIRCULATION; CORONARY SINUS; CYTOTOXICITY; DEFIBRILLATION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; NONHUMAN; PRIORITY JOURNAL; RADIOENZYMATIC ASSAY; RESUSCITATION; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; COMBINED MODALITY THERAPY; ELECTRIC COUNTERSHOCK; EPINEPHRINE; EXTRACELLULAR FLUID; HEART VENTRICLES; KINETICS; MYOCARDIAL REPERFUSION; MYOCARDIUM; NOREPINEPHRINE; PROPANOLAMINES; SURVIVAL ANALYSIS; SWINE; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT;

EID: 2542457296     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000128040.43933.D3     Document Type: Article

References (28)

1. Schneider T, Martens PR, Paschen H, et al. Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Circulation. 2000;102:1780-1794.
2. Ditchey RV, Rubio-Perez A, Slinker BK. Beta-adrenergic blockade reduces myocardial injury during experimental cardiopulmonary resuscitation. J Am Coll Cardiol. 1994;24:804-812.
3. Mann DL, Kent RL, Parsons B, et al. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992;85:790-804.
4. Tang W, Weil MH, Sun S, et al. Progressive myocardial dysfunction after cardiac resuscitation. Crit Care Med. 1993;21:1046-1050.
5. Tang W, Weil MH, Sun S, et al. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation. 1995;92:3089-3093.
6. Waldenstrom AP, Hjalmarson AC, Thornell L. A possible role of noradrenaline in the development of myocardial infarction. Am Heart J. 1978;95:43-51.
7. Position of the American Heart Association on research animal use. Circulation. 1985;71:849A-850A.
8. Farrell DM, Wei C-C, Tallaj I, et al. Angiotensin II modulates catecholamine release into interstitial fluid of canine myocardium in vivo. Am J Physiol. 2001;281:H813-H822.
9. Akiyama T, Yamazaki T, Ninomiya I. In vivo monitoring of myocardial interstitial norepinephrine by dialysis technique. Am J Physiol. 1991;260:H1643-H1647.
10. Valenzuela TD, Roe DJ, Cretin S, et al. Estimating effectiveness of cardiac arrest interventions. Circulation. 1997;96:3308-3313.
11. Glower DD, Spratt JA, Snow ND, et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation. 1985;71:994-1009.
12. Lameris TW, de Zeeuw S, Alberts G, et al. Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. Circulation. 2000;101:2645-2659.
13. Lameris TW, de Zeeuw S, Duncker DJ, et al. Epinephrine in the heart: uptake and release, but no facilitation of norepinephrine release. Circulation. 2002;106:860-865.
14. Eisenhofer G. Concentrations of noradrenaline at neuronal uptake sites during sympathetic nervous inhibition and activation in rabbits. Neurochem Int. 1993;22:493-499.
15. Lameris TW, van den Meiracker AH, Boomsma F, et al. Catecholamine handling in the porcine heart: a microdialysis approach. Am J Physiol. 1999;277:H1562-H1569.
16. Kloeck W, Cummins RO, Chamberlain D, et al. The universal advanced life support algorithm: an advisory statement from the Advanced Life Support Working Group of the International Liaison Committee on Resuscitation. Circulation. 1997;95:2180-2182.
17. Berg RA, Otto CW, Kern KB, et al. High-dose epinephrine results in greater early mortality after resuscitation from prolonged cardiac arrest in pigs: a prospective, randomized study. Crit Care Med. 1994;22:282-290.
18. Ditchey RV, Horwitz LD. Metabolic evidence of inadequate coronary blood flow during closed-chest resuscitation. Cardiovasc Res. 1985;19:419-425.
19. Ditchey RV, Lindenfeld J. Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation. 1988;78:382-389.
20. Foley PJ, Tacker WA, Wortsman J, et al. Plasma catecholamine and serum cortisol responses to experimental cardiac arrest in dogs. Am J Physiol. 1987;253:E283-E289.
21. Kern KB, Elchisak MA, Sanders AB, et al. Plasma catecholamines and resuscitation from prolonged cardiac arrest. Crit Care Med. 1989;17:786-791.
22. Armour JA. Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta I- and beta 2-adrenoceptors. Can J Cardiol. 1997;13:277-284.
23. Schomig A, Richardt G. The role of catecholamines in ischemia. J Cardiovasc Pharmacol. 1990;16:S105-S112.
24. Herlitz J, Ekstrom L, Wennerblom B, et al. Adrenaline in out-of-hospital ventricular fibrillation: does it make any difference? Resuscitation. 1995;29:195-210.
25. Scorsin M, Mebazaa A, Al Attar N, et al. Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardioplegia. J Thorac Cardiovasc Surg. 2003;124:1022-1029.
26. Deng Y-K, Wei F, Li Z-L, et al. Esmolol protects the myocardium and facilitates direct version intracardiac operation with a beating heart. Circ J. 2002;66:715-717.
27. Opie LH, Walpoth B, Barsacchi R. Calcium and catecholamines: relevance to cardiomyopathies and significance in therapeutic strategies. J Mol Cell Cardiol. 1985;17:21-34.
28. Bloom S, Davis DL. Calcium as mediator of isoproterenol-induced myocardial necrosis. Am J Pathol. 1972;69:459-470.